CRISPR stocks tank after research shows edited cells might cause cancer By: CNBC.com News June 11, 2018 at 13:56 PM EDT The new research could pose a major setback to the treatment that has has been hailed as a breakthrough. Read More >> Related Stocks: Crispr Therapeutics Ag Editas Medicine Intellia Thera CS Sangamo Therapeutics